Combining two technologies: Multifunctional polymers and self-nanoemulsifying drug delivery system (SNEDDS) for oral insulin administration

International Journal of Biological Macromolecules

Volumn 61, Issue , 2013, Pages 363-372

  Sakloetsakun, Duangkamon ^a   Dünnhaupt, Sarah ^b   Barthelmes, Jan ^b   Perera, Glen ^b   Bernkop Schnürch, Andreas ^b  

^a KHON KAEN UNIVERSITY   (Thailand)

^b UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Bioavailability; Chitosan thioglycolic acid; Insulin; Nanoemulsion; Self micro nanoemulsifying drug delivery system; Thiolated chitosan

Indexed keywords

CAPTEX 355; CHITOSAN; EMULSIFYING AGENT; INSULIN; MIGLYOL; OCTANOIN; THIOGLYCOLIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG ADMINISTRATION ROUTE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG STABILITY; IN VITRO STUDY; IN VIVO STUDY; MALE; NANOEMULSION; NONHUMAN; PARTICLE SIZE; POLYMERIZATION; PROCESS OPTIMIZATION; RAT;

BIOAVAILABILITY; CHITOSAN-THIOGLYCOLIC ACID; INSULIN; NANOEMULSION; SELF-MICRO/NANOEMULSIFYING DRUG DELIVERY SYSTEM; THIOLATED CHITOSAN;

ADMINISTRATION, ORAL; ANIMALS; BIOPOLYMERS; CELL LINE; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; EMULSIONS; HUMANS; INSULIN; NANOPARTICLES; RATS;

EID: 84882782878     PISSN: 01418130     EISSN: 18790003     Source Type: Journal    
DOI: 10.1016/j.ijbiomac.2013.08.002     Document Type: Article

References (39)

1. Constantinides P., Welzel G., Ellens H., Smith P., Sturgis S., Yiv S., Owen A. Pharm. Res. 1996, 13:210-215.
2. Wakerly M.G., Pouton C.W., Meakin B.J., Morton F.S. ACS Symp. Ser. 1986, 311:242-255.
3. Neslihan Gursoy R., Benita S. Biomed. Pharmacother. 2004, 58:173-182.
4. Constantinides P., Scalart J., Lancaster C., Marcello J., Marks G., Ellens H., Smith P., Formulation Pharm. Res. 1994, 11:1385-1390.
5. Ponchel G., Irache J. Adv. Drug. Deliv. Rev. 1998, 34:191-219.
6. Bernkop-Schnürch A. Eur. J. Pharm. Sci. 2013, 43(49):272-277.
7. Humberstone A.J., Charman W.N. Adv. Drug. Deliv. Rev. 1997, 25:103-128.
8. Ma E., Ma H., Liu Z., Zheng G., Duan M. Acta Pharmacol. Sin. 2006, 27:1382-1388.
9. Bernkop-Schnürch A., Krauland A., Leitner V., Palmberger T. Eur. J. Pharm. Biopharm. 2004, 58:253-263.
10. Leitner V.M., Walker G.F., Bernkop-Schnurch A. Eur. J. Pharm. Biopharm. 2003, 56:207-278.
11. Krauland A., Guggi D., Bernkop-Schnürch A. J. Control. Release 2004, 95:547-555.
12. Greindl M. Oral Drug Delivery: Design and In Vitro/In Vivo Evaluation of Novel Permeation Enhancers and Efflux Pump Inhibitors 2008, Universtiy of Innsbruck, Innsbruck.
13. Bernkop-Schnürch A., Brandt U., Clausen A. Sci. Pharm. 1999, 67:197-208.
14. Werle M., Hoffer M. J. Control. Release 2006, 111:41-46.
15. Patel P., Chaulang G., Akolkotkar A., Mutha S., Hardikar S., Bhosale A. Res. J. Pharm. Technol. 2008, 2:1738-1745.
16. Watnasirichaikul S., Davies N., Rades T., Tucker I. Pharm. Res. 2000, 17:684-689.
17. Watnasirichaikul S., Rades T., Tucker I., Davies N. J. Pharm. Pharmacol. 2002, 54:473-480.
18. Marschütz M., Bernkop-Schnürch A. Biomaterials 2000, 21:1499-1507.
19. Deutel B., Greindl M., Thaurer M., Bernkop-Schnürch A. Biomacromolecules 2008, 9:278-285.
20. Bernkop-Schnürch A., Pinter Y., Guggi D., Kahlbacher H., Schöffmann G., Schuh M., Schmerold I., Schuh M. J. Control. Release 2005, 106:26-33.
21. Balakrishnan P., Lee B., Oh D., Kim J., Lee Y., Kim D., Jee J., Lee Y., Woo J., Yong C., Choi H. Int. J. Pharm. 2009, 374:66-72.
22. Cuiné J., Charman W., Pouton C., Edwards G., Porter C. Pharm. Res. 2007, 24:748-757.
23. Wakerly M.G., Pouton C.W., Meakin B.J., Morton F.S. Am. Chem. Soc. Symp. Ser. 1986, 311:242-255.
24. Pouton C. Eur. J. Pharm. Sci. 2006, 29:278-287.
25. Charman W.N., Stella V.J. Adv. Drug. Deliv. Rev. 1991, 7:1-14.
26. Parmar N., Singla N., Amin S., Kohli K. Colloids. Surf. B Biointerfaces 2011, 86:327-338.
27. Shafiq-un-Nabi S., Shakeel F., Talegaonkar S., Ali J., Baboota S., Ahuja A., Khar R.K., Ali M. AAPS Pharm. Sci. Technol. 2007, 8:E12-E17.
28. Hintzen F., Laffleur F., Perera G., Mueller C., Bernkop-Schnuerch A. XI International Conference on Nanostructured Materials 2012, Rhodos, Greece.
29. Iqbal J., Sakloetsakun D., Bernkop-Schnürch A. Eur. J. Pharm. Biopharm. 2011, 78:361-365.
30. Akiyama Y., Nagahara N., Nara E., Kitano M. J. Pharm. Pharmacol. 1998, 50:159-166.
31. Bernkop-Schnürch A. J. Control. Release 1998, 52:1-16.
32. Muranishi S. Crit. Rev. Ther. Drug. Carrier. Syst. 1990, 7:1-33.
33. Gualandi-Signorini A.M., Giorgi G. Eur. Rev. Med. Pharmacol. Sci. 2001, 5:73-83.
34. Davalli A.M., Ogawa Y., Scaglia L., Wu Y.J., Hollister J., Bonner-Weir S., Weir G.C. Diabetes 1995, 44:104-111.
35. Reddy P.M., Dkhar S.A., Subramanian R. BMC Pharmacol. 2006, 6:1-7.
36. Stoll R.W., Touber J.L., Menahan L.A., Williams R.H. Proc. Soc. Exp. Biol. Med. 1970, 133:894-896.
37. Richter B., Neises G. Cochrane. Database Syst. Rev. 2005, CD003816.
38. Sakloetsakun D., Perera G., Hombach J., Millotti G., Bernkop-Schnürch A. AAPS Pharm. Sci. Technol. 2010, 11:1185-1192.
39. Peddyreddy M.K., Dkhar S.A., Ramaswamy S., Naveen A.T., Shewade D.G. World J. Gastroenterol. 2006, 12:2593-2600.